Teva Set For Immediate US Launch Of Austedo In Tardive Dyskinesia

FDA-approved labeling includes boxed warning for depression and suicidality, though this is specific for Huntington's disease patients, who are prone to these conditions.

FDA approved background, 3D rendering, blue street sign

More from New Products

More from Scrip